"An April 2007 online paper in Vaccine showed a similar T cell response potentiation, this time with 60 healthy subjects being administered Novartis' Agrippal influenza vaccine.[7] This study, initiated in 2005 and completed in mid-2006, compared the influenza vaccine with the vaccine plus efti at doses up to 100 µg. For subjects that received efti there were higher levels of Th1-type CD4+ T cells in PBMC." Wikipedia
Does anyone know why this didnt progress? was overall efficacy not improved?
"An April 2007 online paper in Vaccine showed a similar T cell...
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 37.0¢ | 33.0¢ | $21.16M | 61.97M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 408105 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 153724 | 1 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |